HomeAI · summaries
Storia in 4 fonti
Pharmalittle: We're reading about a U.S. peptide panel's votes, Amgen scuffling with the FDA, and more
An FDA panel recommended that compounding pharmacies be allowed to make two more peptides, a step toward RFK Jr.'s goal to make them more available
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Pharmalittle: We're reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs
- ·
medpagetoday.com
FDA Panel Finds a Peptide It Doesn't Like
Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list
